We are a science-led, patient-focused pharmaceutical company committed to delivering innovative medicines that aim to transform the lives of patients, with improved outcomes and a better quality of life.
Our operations in Malaysia uniquely hosts the Commercial business, Site Management and Monitoring and Global Financial Services, demonstrating our commitment to bringing in science and innovation to help patients and boosting the employment of skilled talent in the country.
Our bold ambition is to be pioneers in science and transform outcomes for patients through the delivery of innovative, life-changing medicines. The company has been awarded the Top Employer certification for six years in succession, since 2018 and employs over 300 employees.
With a strong focus on global clinical trial delivery, the Site Management and Monitoring department was established in 2022 to bridge the science in global R&D and our patients in Malaysia. The team brings alternative treatment options to the patients and plays a crucial role in pushing the boundaries of science to deliver new medicines and lead in our disease areas.
The Global Financial Services was established in 2008 to provide financial, accounting and business support for AstraZeneca’s operations in the Asia Pacific region and its partners globally. The Malaysia hub is one of the three shared services hubs globally and builds on the growth of the global business services sector in Malaysia. It has a diverse workforce of over 400 employees, reflecting its commitment to develop talent in finance functions.
We foster an inclusive culture that champions diversity and collaboration and we reward for innovation, entrepreneurship and high performance.